Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesHypercholesterolaemia induces early renal lesions characterized by upregulation of MMP-9 and iNOS and ETAR: alleviated by a dual endothelin receptor antagonist CPU0213 and simvastatin
Journal of Pharmacy and Pharmacology, 05/27/09
Luo L et al. - CPU0213 relieves renal lesions by blunting hypercholesterolaemia caused by the upregulated ET system, iNOS and MMP-9 in the kidney. This indicates that CPU0213 is promising in treating patients with end stage renal disease.
Related Articles
Changing Epidemiology of End-Stage Renal Disease in Last 10 Years in Iran
Iranian Journal of Kidney Diseases, 10/13/09
Relevance Score: 69%
Diabetic kidney disease in the older adult: an update
Aging Health, 10/07/09
Relevance Score: 69%
Non-healing Skin Ulcers Secondary to Calciphylaxis with Fungemia in an End-stage Renal Disease Patient
Hong Kong Journal of Nephrology, 10/07/09
Relevance Score: 69%
Anabolic and Catabolic Mechanisms in End-Stage Renal Disease
Advances In Chronic Kidney Disease, 10/06/09
Relevance Score: 69%
Renal transplantation in a HIV positive patient
Indian Journal of Nephrology, 10/20/09
Relevance Score: 68%
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders
Journal of Dermatological Treatment , 12/04/09
Non-psoriatic dermatologic uses of monoclonal antibody therapy
Journal of Dermatological Treatment , 12/04/09
Does Simvastatin Cause More Myotoxicity Compared with Other Statins
Annals of Pharmacotherapy, 12/03/09
Sponsor
Article Search
Sponsor